Medizone International Announces Sale of Warrants Salt Lake City, UT - September 10, 1997, - Medizone International, Inc. ("Medizone") (OTC.BB:MZEI.U) announced today that it has completed the sale of one-half of the $0.07 warrants authorized by the Company's board of directors in June. The Sand Dollar Solution acquired the $0.07 warrants, raising approximately $525,000.00 for the Company. The Company's Board of Directors unanimously voted to extend the remaining $0.07 warrants, which were due to expire September 10, 1997, until the Company has completed its audit which is in progress and bring its Security Exchange Commission (SEC) filing up-to-date. Edwin Marshall, Chairman said, "We are pleased about obtaining the first part of this funding. It will allow Medizone to complete its move to Salt Lake City where Milton Adair will be taking up the role as Chief Executive Officer on a full-time basis. Additionally, it provides us with adequate funding to start our Italian human trials. Sand Dollar intends to excercise the balance of the first warrants upon completion of the audit and SEC filings." As part of the Company's restructuring plan announced in June of 1997, the Medizone board approved the issuing of $11 million of warrants to Sand Dollar to raise funds for Medizone. The warrants are exercisable in three increments with prices set at $0.07, $0.15 and $0.20. The first increment should raise just over $1 million. The second increment of warrants expire June 12, 1999 and should raise an additional $5 million for the Company.